Updating the biological interest of 'Valeriana officinalis'

  1. Sánchez, Marta 1
  2. González-Burgos, Elena 1
  3. Iglesias, Irene 1
  4. Gómez-Serranillos Cuadrado, M. Pilar 1
  1. 1 University Complutense of Madrid. Department of Pharmacology, Pharmacognosy and Botany.
Revista:
Mediterranean Botany

ISSN: 2603-9109

Año de publicación: 2021

Volumen: 42

Tipo: Artículo

DOI: 10.5209/MBOT.70280 DIALNET GOOGLE SCHOLAR lock_openAcceso abierto editor

Otras publicaciones en: Mediterranean Botany

Resumen

Valeriana officinalis L. (Caprifoliaceae) has been traditionally used to treat mild nervous tension and sleep problems. The basis of these activities are mainly attributed to valerenic acid through the modulation of the GABA receptor. Moreover, V. officinalis is claimed to have other biological activities such as cardiovascular benefits, anticancer, antimicrobial and spasmolytic.  The current review aims to update the biological and pharmacological studies (in vitro, in vivo and clinical trials) of V. officinalis and its major secondary metabolites in order to guide future research. Databases PubMed, Science Direct and Scopus were used for literature search including original papers written in English and published between 2014 and 2020. There have been identified 33 articles which met inclusion criteria. Most of these works were performed with V. officinalis extracts and only a few papers (in vitro and in vivo studies) evaluated the activity of isolated compounds (valerenic acid and volvalerenal acid K). In vitro studies focused on studying antioxidant and neuroprotective activity. In vivo studies and clinical trials mainly investigated activities on the nervous system (anticonvulsant activity, antidepressant, cognitive problems, anxiety and sleep disorders). Just few studies were focused on other different activities, highlight effects on symptoms of premenstrual and postmenopausal syndromes. Valeriana officinalis continues to be one of the medicinal plants most used by today's society for its therapeutic properties and whose biological and pharmacological activities continue to arouse great scientific interest as evidenced in recent publications. This review shows scientific evidence on traditional uses of V. officinalis on nervous system.

Referencias bibliográficas

  • Ahmadi, M., Khalili, H., Abbasian, L. & Ghaeli, P. 2017. Effect of Valerian in Preventing Neuropsychiatric Adverse Effects of Efavirenz in HIV-Positive Patients: A Pilot Randomized, Placebo-Controlled Clinical Trial. Ann. Pharmacother. 51(6): 457-464.
  • Anand, P. & Singh, B. 2013. A review on cholinesterase inhibitors for Alzheimer's disease. Arch. Pharm. Res. 36(4): 375-99.
  • Azizi, H., Shojaii, A., Hashem-Dabaghian, F., Noras, M., Boroumand, A., Ebadolahzadeh Haghani, B. & Ghods, R. 2020. Effects of Valeriana officinalis (Valerian) on tension-type headache: A randomized, placebo-controlled, double-blind clinical trial. Avicenna J Phytomed. 10(3): 297–304.
  • Bagheri-Nesami, M., Gorji, M.A., Rezaie, S., Pouresmail, Z. & Cherati, J.Y. 2015. Effect of acupressure with valerian oil 2.5% on the quality and quantity of sleep in patients with acute coronary syndrome in a cardiac intensive care unit. J. Tradit. Complement. Med. 5(4): 241-247.
  • Baxter, A.J., Scott, K.M., Vos, T. & Whiteford, H.A. 2013. Global prevalence of anxiety disorders: a systematic review and meta-regression. Psychol. Med. 43(5): 897-910.
  • Becker, A., Felgentreff, F., Schröder, H., Meier, B. & Brattström, A. 2014. The anxiolytic effects of a Valerian extract is based on valerenic acid. BMC Complement. Altern. Med. 14: 267.
  • Behboodi Moghadam, Z., Rezaei, E., Shirood Gholami, R., Kheirkhah, M. & Haghani, H. 2016. The effect of Valerian root extract on the severity of premenstrual syndrome symptoms. J. Tradit. Complement. Med. 6(3): 309-15.
  • Bent, S., Padula, A., Moore, D., Patterson, M. & Mehling, W. 2006. Valerian for sleep: a systematic review and meta-analysis. Am. J. Med. 119(12): 1005-1012.
  • Caudal, D., Guinobert, I., Lafoux, A., Bardot, V., Cotte, C., Ripoche, I., Chalard, P. & Huchet, C. 2017. Skeletal muscle relaxant effect of a standardized extract of Valeriana officinalis L. after acute administration in mice. J. Tradit. Complement. Med. 8(2): 335-340.
  • Chen, H.W., He, X.H., Yuan, R., Wei, B.J., Chen, Z., Dong; J.X. & Wang, J. 2016. Sesquiterpenes and a monoterpenoid with acetylcholinesterase (AchE) inhibitory activity from Valeriana officinalis var. latiofolia in vitro and in vivo. Fitoterapia. 110: 142-149.
  • Chen, H.W., Chen, L., Li, B., Yin, H.L., Tian, Y., Wang, Q., Xiao, Y.H. & Dong, J.X. 2013. Three new germacrane-type sesquiterpenes with NGF-potentiating activity from Valeriana officinalis var. latiofolia. Molecules 18(11): 14138-14147
  • Chen, H.W., Wei, B.J., He, X.H., Liu, Y. & Wang, J. 2015. Chemical Components and Cardiovascular Activities of Valeriana spp. Evid. Based. Complement. Alternat. Med. 2015: 947619.
  • EMA/HMPC/150848/2015. Committee on Herbal Medicinal Products (HMPC) European Union herbal monograph on Valeriana officinalis L., radix. 2016.
  • European Scientific Cooperative on Phytotherapy. ESCOP monographs The Scientific Foundation for Herbal Medicinal Products. 2nd edition. Exeter (Reino Unido): ESCOP, Stuttgart: Georg Thieme Verlag, New York: Thieme New York. 2003.
  • Farah, G.J., Ferreira, G.Z., Danieletto-Zanna, C.F., Luppi, C.R. & Jacomacci, W.P. 2019. Assessment of Valeriana officinalis l. (Valerian) for Conscious Sedation of Patients during the Extraction of Impacted Mandibular Third Molars: A Randomized, Split-Mouth, Double-Blind, Crossover Study. J. Oral Maxillofac. Surg. 77(9): 1796.
  • Felgentreff, F., Becker, A., Meier, B. & Brattström, A. 2012. Valerian extract characterized by high valerenic acid and low acetoxy valerenic acid contents demonstrates anxiolytic activity. Phytomedicine.19(13): 1216-1222.
  • GBD 2016 Dementia Collaborators. 2019. Global, regional, and national burden of Alzheimer's disease and other dementias, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 18(1): 88-106.
  • GBD 2016 Epilepsy Collaborators. 2019. Global, regional, and national burden of epilepsy, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 18(4): 357-375.
  • GBD 2016 Parkinson's Disease Collaborators. 2018. Global, regional, and national burden of Parkinson's disease, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 17(11): 939-953.
  • GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. 2018. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 392(10159): 1789-1858.
  • Gharib, M., Samani, L.N., Panah, Z.E., Naseri, M., Bahrani, N. & Kiani, K. 2015. The effect of valeric on anxiety severity in women undergoing hysterosalpingography. Glob. J. Health. Sci. 7(3): 358-363.
  • Gonulalan, E.M., Bayazeid, O., Yalcin, F.N. & Demirezer, L.O. 2018. The roles of valerenic acid on BDNF expression in the SH-SY5Y cell. Saudi Pharm. J. 26(7): 960-964.
  • Hamaidia, M., Barez, P., Carpentier, A. Lebecque, S., Miazek, K., Paul, A., Sriramareddy, S.N., Staumont, B., Danthine, B., Deleu, M., Frederich, M., De Pauw, E., Delaplace, P., Delvigne, F., Goffin, D., Ongena, M., Duysinx, B., Louis, R., Cosse, J.P. & Willems, L. 2016. From Valeriana officinalis to cancer therapy: The success of a bio-sourced compound. Biotechnol. Agron. Soc. Environ 20(S1): 314-320
  • Harada, K., Kato, Y., Takahashi, J, Imamura, H., Nakamura, N., Nishina, A., Phay, N., Tadaishi, M., Shimizu, M. & Kobayashi-Hattori, K. 2020. The Effect of Methanolic Valeriana officinalis Root Extract on Adipocyte Differentiation and Adiponectin Production in 3T3-L1 Adipocytes. Plant Foods Hum Nutr. 75(1): 103‐109.
  • Hassani, S., Alipour, A., Darvishi Khezri, H., Firouzian, A., Zeydi, A.E., Baradari, A.G., Ghafari, R., Habibi, W.A., Tahmasebi, H., Alipour, F. & Zadeh, P.E. 2015. Can Valeriana officinalis root extract prevent early postoperative cognitive dysfunction after CABG surgery? A randomized, double-blind, placebo-controlled trial. Psychopharmacology 232(5): 843-850.
  • Heidarian, A., Delavioz, H. & Roozbehi, A. Evaluation of the effects of valeriana officinalis hydroalcoholic extract on the morphology of cerebral hippocampus astrocytes in rats. 2020. Int J Pharmaceut Med. 12(1): 1-5.
  • Iasella, C.J., Johnson, H.J. & Dunn, M.A. Adverse Drug Reactions: Type A (Intrinsic) or Type B (Idiosyncratic).2017. Clin Liver Dis. 21(1): 73-87.
  • Jenabi, E., Shobeiri, F., Hazavehei, S.M.M. & Roshanaei, G. 2018. The effect of Valerian on the severity and frequency of hot flashes: A triple-blind randomized clinical trial. Women Health. 58(3): 297-304.
  • Johnson, Q., Borsheski, R.R. & Reeves-Viets, J.L. 2013. Pain management mini-series. Part I. A review of management of acute pain. Mo Med. 110(1): 74-79.
  • Jung, H.Y., Yoo, D.Y., Kim, W., Nam, S.M., Kim, J.W., Choi, J.H., Kwak, Y.G., Yoon, Y.S. & Hwang, I.K. 2014. Valeriana officinalis root extract suppresses physical stress by electric shock and psychological stress by nociceptive stimulation-evoked responses by decreasing the ratio of monoamine neurotransmitters to their metabolites. BMC Complement. Altern. Med. 11;14: 476.
  • Jung, H.Y., Yoo, D.Y., Nam, S.M. Kim,J.W., Choi, J.H.,Yoo, M., Lee, S., Yoon, Y.S. & Hwang, I.K. 2015. Valerenic Acid Protects Against Physical and Psychological Stress by Reducing the Turnover of Serotonin and Norepinephrine in Mouse Hippocampus-Amygdala Region. J. Med. Food. 18(12): 1333-1339.
  • Кatsarova, M., Dimitrova, S., Lukanov, L., Sadakov, S., Denev, P., Plotnikov, E., Kandilarov, I. & Kostadinova, I. 2018. Antioxidant activity and nontoxicity of extracts from Valeriana officinalis, Мelissa officinalis, Crataegus monogyna, Hypericum perforatum, Serratula coronatа and combinations antistress 1 and antistress 2. Bulg. Chem. 49: 93-98
  • Kelber, O., Nieber, K., & Kraft, K. 2014. Valerian: no evidence for clinically relevant interactions. Evid Based Complement Alternat Med.;2014:879396.
  • Letchamo, W., Ward, W., Heard, B. & Heard, D. Essential oil of Valeriana officinalis L. cultivars and their antimicrobial activity as influenced by harvesting time under commercial organic cultivation. J Agric Food Chem. 2004;52(12): 3915-3919.
  • Li, Y., Liu, Y., Xiao, B., Yang, J.I. & Huang, R.Q. 2015. Dynamic Comparison of Free Radical Scavenging Abilities of Hypericum Perforatum L., Herba Verbenae Officinalis, and Valeriana Officinalis L. Extracts. Phcog. J. 7(3): 198-204.
  • Mineo, L., Concerto, C., Patel, D. Mayorga, T., Paula, M., Chusid, E., Aguglia, E. & Battaglia, F. 2017. Valeriana officinalis Root Extract Modulates Cortical Excitatory Circuits in Humans. Neuropsychobiology. 75(1): 46-51.
  • Neamati, A., Chaman, F., Hosseini, M. & Boskabady, M.H. 2014. The effects of Valeriana officinalis L. hydro-alcoholic extract on depression like behavior in ovalbumin sensitized rats. J. Pharm. Bioallied. Sci. 6(2): 97-103.
  • Neha, K., Haider, M.R., Pathak, A. & Yar, M.S. 2019. Medicinal prospects of antioxidants: A review. Eur. J. Med. Chem. 178: 687-704.
  • Occhiuto, F., Pino. A., Palumbo, D.R., Samperi, S., De Pasquale, R., Sturlese, E. & Circosta, C. 2009. Relaxing effects of Valeriana officinalis extracts on isolated human non pregnant uterine muscle. J. Pharm. Pharmacol. 61(2): 251-256.
  • Onyszkiewicz, M., Gawrys-Kopczynska, M., Sałagaj, M., Aleksandrowicz, M., Sawicka, A., Koźniewska, E., Samborowska, E. & Ufnal, M. 2020. Valeric acid lowers arterial blood pressure in rats. Eur. J. Pharmacol. 877: 173086.
  • Patocka, J. & Jakl, J. 2010. Biomedically relevant chemical constituents of Valeriana officinalis. J. Appl. Biomed. 8: 11–18.
  • Pilerood, S.A. & Prakash, J. 2014. Evaluation of nutritional composition and antioxidant activity of Borage (Echium amoenum) and Valerian (Valeriana officinalis). J. Food. Sci. Technol. 51(5): 845-854.
  • Pinheiro, M.L., Alcântara, C.E., de Moraes, M. & de Andrade. E.D. 2014. Valeriana officinalis L. for conscious sedation of patients submitted to impacted lower third molar surgery: A randomized, double-blind, placebo-controlled split-mouth study. J. Pharm. Bioallied. Sci. 6(2): 109-14.
  • Quintans Júnior, L.J., Almeida, J.R.G.S., Lima, J.T., Nunes, X.P., Siqueira, J.S., Gomes de Oliveira, L.E., Almeida, R.N., de Athayde-Filho, P.F. & Barbosa-Filho, J.M. 2008. Plants with anticonvulsant properties: a review. Rev. Bras. Farmacogn. 18: 798-819.
  • Rodríguez-Cruz, A., Romo-Mancillas, A., Mendiola-Precoma, J., Escobar-Cabrera, J. E., García-Alcocer, G. & Berumen, L. C. 2019. Effect of valerenic acid on neuroinflammation in a MPTP-induced mouse model of Parkinson's disease. IBRO Rep. 8: 28-35.
  • Roh, D., Jung, J.H., Yoon, K.H. Lee, K.H., Kang, L.Y., Lee, S.K., Shin, K. & Kim, D.H. 2019. Valerian extract alters functional brain connectivity: A randomized double-blind placebo-controlled trial. Phytother. Res. 33(4): 939-948.
  • Samaei, A., Nobahar, M., Hydarinia-Naieni, Z., Abbas Ali Ebrahimian, A.A.,Tammadon, M.R., Ghorbani, R. & Vafaei, A.A. . 2018. Effect of valerian on cognitive disorders and electroencephalography in hemodialysis patients: a randomized, cross over, double-blind clinical trial. BMC Nephrol. 19(1): 379.
  • Sundaresan, N., Narayanan, K. & Ilango, K. 2018. Valeriana officinalis: A review of its traditional uses, phytochemistry and pharmacology. Asian J. Pharm. Clin. Res.11 (1): 36-41.
  • Taherianfard, M. & Karamifard, M. 2018. Evaluation of the GABAA receptor on pain sensitivity in male rat pretreated with valeriana officinalis extract using formalin test. Physiol. Pharmacol. 22: 118-123.
  • Thomas, K., Canedo, J., Perry, P.J., Shadi Doroudgar, D., Lopes, I., Chuang, H.M. & Bohnert, K. 2016. Effects of valerian on subjective sedation, field sobriety testing and driving simulator performance. Accid. Anal. Prev. 92: 240-244.
  • Torres-Hernández, B.A., Colón, L.R., Rosa-Falero, C. Aranza Torrado, A., Miscalichi, N., Ortíz, J.G., González-Sepúlveda, L., Pérez-Ríos, N., Erick Suárez-Pérez, E., Bradsher, J.N. & Behra, M. 2016. Reversal of pentylenetetrazole-altered swimming and neural activity-regulated gene expression in zebrafish larvae by valproic acid and valerian extract. Psychopharmacology. 233(13): 2533-47.
  • Torres-Hernández, B.A., Del Valle-Mojica, L.M. & Ortíz, J.G. 2015. Valerenic acid and Valeriana officinalis extracts delay onset of Pentylenetetrazole (PTZ)-Induced seizures in adult Danio rerio (Zebrafish). BMC Complement. Altern. Med. 15: 228.
  • Wang, P.C., Ran, X.H., Luo, H.R., Ma, Q.Y., Liu, Y.Q., Zhou, J. & Zhao, Y.X. 2013. Phenolic compounds from the roots of Valeriana officinalis var. latifolia. J. Braz. Chem. Soc. 24: 1544-1548.
  • Wang, P.C., Ran, X.H., Chen, R., Lou, H.R., Liu, Y.Q., Zhou, J. & Zhao, Y.X. 2010. Germacrane-type sesquiterpenoids from the roots of Valeriana officinalis var. latifolia. J. Nat.Prod. 73(9): 1563-1567.
  • Yoo, D.Y., Jung, H.Y., Nam, S.M., Kim, J.W., Choi, J.H., Kwak, Y.G., Yoo, M., Lee, S., Yoon, Y.Y. & Hwang, I.K. 2015. Valeriana officinalis Extracts Ameliorate Neuronal Damage by Suppressing Lipid Peroxidation in the Gerbil Hippocampus Following Transient Cerebral Ischemia. J. Med. Food. 18(6): 642-647.
  • Zare, A., Khaksar, Z., Sobhani, Z. & Amini, M. 2018. Analgesic Effect of Valerian Root and Turnip Extracts. World J. Plast. Surg. 7(3): 345-350.
Fuente de los datos: Dialnet